NCT00024804 2026-03-11
A Natural History Study of Bone and Mineral Disorders
National Institutes of Health Clinical Center (CC)
Recruiting
Clinical Trials
20 trialsNCT07379008 2026-01-30
Safety and Efficacy of Non-Setting Paste in Bone Defect Reconstruction
Biovico Sp. z o.o.
Phase NA Completed
NCT05115331 2025-05-31
1-2 PUNCH
University of Cincinnati
Phase 3 Active not recruiting
NCT04842071 2024-02-07
18F-sodium Fluoride (NaF) PET to Replace Bone Scintigraphy: Safety and Efficacy Assessment
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Phase 3 Unknown
NCT03960437 2023-09-21
Parsabiv-MBD
Columbia University
Phase 2 Completed
NCT01345019 2022-11-08
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma
Amgen
Phase 3 Completed
NCT03905174 2022-06-07
MING
Royal National Orthopaedic Hospital NHS Trust
Phase NA Unknown
NCT01200017 2021-05-27
Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant
University of California, San Francisco
No longer available
NCT04117594 2021-05-19
WISE
Royal Marsden NHS Foundation Trust
Unknown
NCT03072186 2021-04-26
ICG2
Ohio State University
Phase NA Completed
NCT02439112 2020-12-17
EMMY
Zealand University Hospital
Phase NA Completed
NCT03050203 2019-01-28
kit
Istituto Ortopedico Rizzoli
Phase NA Completed
NCT03129230 2018-11-27
Free Nonvascularized Fibula Autograft for Tumor-like Lesions in Femoral Neck Using in Pediatric Patients
Yulin Orthopedics Hospital of Chinese and Western Medicine
Phase NA Completed
NCT00399802 2018-08-16
A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED)
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT02575352 2018-05-25
CPC
Graftys SA
Unknown
NCT01582295 2017-05-25
XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease
Massachusetts General Hospital
Phase 1 Completed
NCT02442063 2016-11-30
Phase Ib Study of Radium Ra 223 Dichloride in Combination With Paclitaxel in Cancer Subjects With Bone Lesions
Bayer
Phase 1 Completed
NCT02101164 2015-02-18
Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease
Amgen
Phase 4 Withdrawn
NCT01325142 2014-12-02
Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer
University of Michigan
Completed
NCT00741377 2013-02-18
A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients
Novartis
Phase 1 Completed